Breast cancer risk in NF1-deleted patients

Laurence Pacot^{1

2}, Julien Masliah-Planchon³, Adina Petcu⁴, Benoit Terris⁵, Marion Gauthier Villars³, James Lespinasse⁶, Pierre Wolkenstein^{7

8}, Anne Vincent-Salomon⁹, Dominique Vidaud^{1

2}, Eric Pasmant^{10

2}

Affiliations

¹ Institut Cochin, Inserm U1016, CNRS UMR8104, Université Paris Cité, CARPEM, Paris, France.
² Department of genetics, Fédération de Génétique et Médecine Génomique, Hôpital Cochin, DMU BioPhyGen, AP-HP.Centre-Université Paris Cité, Paris, France.
³ Department of Genetics, Curie Institute Hospital Group, Paris, France.
⁴ Department of Pathology, Centre Hospitalier Métropole Savoie, Chambery, France.
⁵ Department of Pathology, Hôpital Cochin, Assistance Publique-Hopitaux de Paris, Paris, France.
⁶ Unité de Génétique médicale, Centre Hospitalier Métropole Savoie, Chambéry, France.
⁷ Department of Dermatology, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France.
⁸ Centre d'Investigation Clinique 1430, INSERM, Hôpital Henri-Mondor, Assistance Publique-Hôpitaux de Paris, Referral Center of Neurofibromatosis, Créteil, France.
⁹ Department of Pathology, Curie Institute Hospital Group, Paris, Île-de-France, France.
¹⁰ Institut Cochin, Inserm U1016, CNRS UMR8104, Université Paris Cité, CARPEM, Paris, France eric.pasmant@inserm.fr.

Laurence Pacot et al. J Med Genet. 2024.

. 2024 Apr 19;61(5):428-429.

doi: 10.1136/jmg-2023-109682.

¹ Institut Cochin, Inserm U1016, CNRS UMR8104, Université Paris Cité, CARPEM, Paris, France.
² Department of genetics, Fédération de Génétique et Médecine Génomique, Hôpital Cochin, DMU BioPhyGen, AP-HP.Centre-Université Paris Cité, Paris, France.
³ Department of Genetics, Curie Institute Hospital Group, Paris, France.
⁴ Department of Pathology, Centre Hospitalier Métropole Savoie, Chambery, France.
⁵ Department of Pathology, Hôpital Cochin, Assistance Publique-Hopitaux de Paris, Paris, France.
⁶ Unité de Génétique médicale, Centre Hospitalier Métropole Savoie, Chambéry, France.
⁷ Department of Dermatology, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France.
⁸ Centre d'Investigation Clinique 1430, INSERM, Hôpital Henri-Mondor, Assistance Publique-Hôpitaux de Paris, Referral Center of Neurofibromatosis, Créteil, France.
⁹ Department of Pathology, Curie Institute Hospital Group, Paris, Île-de-France, France.
¹⁰ Institut Cochin, Inserm U1016, CNRS UMR8104, Université Paris Cité, CARPEM, Paris, France eric.pasmant@inserm.fr.

No abstract available

Keywords: Genetic Counseling; Genetic Predisposition to Disease; Genetics, Medical; Human Genetics; Medical Oncology.

Conflict of interest statement

Competing interests: None declared.